Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: A randomised trial

Lancet

Volumn 353, Issue 9159, 1999, Pages 1136-1139

  Sagliocca, Luciano ^a   Amoroso, Pietro ^b   Stroffolini, Tommaso ^c   Adamo, Brunella ^d   Tosti, Maria Elena ^c   Lettieri, Gennaro ^b   Esposito, Ciro ^b   Buonocore, Salvatore ^b   Pierri, Paola ^b   Mele, Alfonso ^c  

^a SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^c Lab Epidemiologia e Biostatistica   (Italy)

^d Ultrasound Guided and Neck Pathology Surgery   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS A; HOUSEHOLD; HUMAN; INFECTION CONTROL; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VIRUS TRANSMISSION;

EID: 0033519040     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08139-2     Document Type: Article

References (19)

1. Mele A., Stroffolini T., Palumbo F.et al. Incidence and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J Hepatol. 26:1997;743-747.
2. Mele A., Marzolini A., Tosti M.E., Ciccozzi M., Stroffolini T. SEIEVA: Sistema Epidemiologico Integrato dell'Epatite Virale Acuta - rapporto 1995-1996. Rapporto Istisan 97/36 1997.
3. Shapiro C.N., Margolis H.S. Worldwide epidemiology of hepatitis A virus infection. J Hepatol. 18:1993;S11-14.
4. Lednar W.M., Lemon S.M., Kirkpatrick J.W., Redfield R.R., Fields M.L., Keller P.W. Frequency of illness associated with epidemic hepatitis A virus infection in adults. Am J Epidemiol. 122:1985;226-233.
5. Mele A., Rastelli M.G., Gill O.N.et al. Recurrent epidemic hepatitis A associated with consumption of raw shellfish, probably controlled through public health measures. Am J Epidemiol. 130:1989;540-546.
6. Stroffolini T., Biagini W., Lorenzoni L., Palazzesi G.P., Divizia M., Frangillo R. An outbreak of hepatitis A in young adults in central Italy. Eur J Epidemiol. 6:1990;156-159.
7. Hadler S.C., Erben J.J., Matthews D., Starko K., Francis D.P., Maynard J.E. Effect of innunoglobulin on hepatitis A in day-care centers. JAMA. 249:1983;48-53.
8. Winokur P.L., Stapleton J.T. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 14:1992;580-586.
9. Goudemand M., Maniez-Montreuil M., Dupressoir-Burlet M.V. Specific anti-HAV immunoglobulin. Lancet. 342:1993;239.
10. Innis B.L., Snitbhan R., Kunasol P.et al. Protection against hepatitis A by an inactivated vaccine. JAMA. 271:1994;1328-1334.
11. Werzberger A., Mensch B., Kuter B.et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med. 327:1992;453-457.
12. Robertson B.H., D'Hondt E.H., Spelbring J.et al. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection. J Med Virol. 43:1994;249-251.
13. Prikazsky V., Olear V., Cernoch A., Safary A., Andrè F.E. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol. 44:1994;457-459.
14. McMahon B.J., Beller M., Williams J., Schloss M., Households T., Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 150:1996;733-739.
15. Roumeliotou A., Papachristopoulos A., Alexiou D., Papaevangelou V., Stergiou G., Papaevangelou G. Intrafamiliar clustering of hepatitis A. Infection. 22:1994;96-98.
16. Mele A., Pasquini P., Panà A. Hepatitis A in Italy: epidemiology and suggestions for control. Ital J Gastroenterol. 23:1991;341-343.
17. Sackett D.L., Cook R.J. Understanding clinical trials: what measures of efficacy should a journal article provide a busy clinician? BMJ. 309:1994;755-756.
18. Victor J., Knudsen J.D., Nielsen L.P.et al. Hepatitis A vaccine: a new convenient single-dose schedule with booster when long-term immunization is warranted. Vaccine. 12:1994;1327-1329.
19. Centers for Disease Control and Prevention. Hepatitis surveillance. Atlanta: US Department of Health and Human Services. Report 56, 1996.